Your browser doesn't support javascript.
loading
Omniligase-1-Mediated Phage-Peptide Library Modification and Insulin Engineering.
Zhang, Yi Wolf; Lin, Nai-Pin; Guo, Xu; Szabo-Fresnais, Nicolas; Ortoleva, Peter J; Chou, Danny Hung-Chieh.
Afiliação
  • Zhang YW; Department of Pediatrics, Division of Diabetes and Endocrinology, Stanford University, Palo Alto, California 94304, United States.
  • Lin NP; Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States.
  • Guo X; Department of Pediatrics, Division of Diabetes and Endocrinology, Stanford University, Palo Alto, California 94304, United States.
  • Szabo-Fresnais N; Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
  • Ortoleva PJ; Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112, United States.
  • Chou DH; Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
ACS Chem Biol ; 19(2): 506-515, 2024 02 16.
Article em En | MEDLINE | ID: mdl-38266161
ABSTRACT
Chemical and enzymatic modifications of peptide-displayed libraries have been successfully employed to expand the phage display library. However, the requirement of specific epitopes and scaffolds has limited the scope of protein engineering using phage display. In this study, we present a novel approach utilizing omniligase-1-mediated selective and specific ligation on the phage pIII protein, offering a high conversion rate and compatibility with commercially available phage libraries. We applied this method to perform high-throughput engineering of insulin analogues with randomized B chain C-terminal regions. Insulin analogues with different B chain C-terminal segments were selected and exhibited biological activity equivalent to that of human insulin. Molecular dynamics studies of insulin analogues revealed a novel interaction between the insulin B27 residue and insulin receptor L1 domain. In summary, our findings highlight the potential of omniligase-1-mediated phage display in the development and screening of disulfide-rich peptides and proteins. This approach holds promise for the creation of novel insulin analogues with enhanced therapeutic properties and exhibits potential for the development of other therapeutic compounds.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bacteriófagos / Biblioteca de Peptídeos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bacteriófagos / Biblioteca de Peptídeos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article